-
effectivehealthcare.ahrq.gov/health-topics/gastrointestinal-bleeding
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - outcomes between ESA responders
and non-responders as has been suggested in ESA trials in the chronic kidney … disease setting ?
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-nerve-problems
-
effectivehealthcare.ahrq.gov/health-topics/foodborne-illness
-
effectivehealthcare.ahrq.gov/health-topics/diabetes-type-2
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Bethesda (MD): National
Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK); 2013 Sep
-
effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
March 29, 2012 - 93
Abstract
This chapter addresses strategies for selecting variables for adjustment in nonexperimental comparative
effectiveness research (CER), and uses causal graphs to illustrate the causal network relating treatment
to outcome. While selection approaches should be based on an understanding of the causal networ…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
January 01, 2015 - Research
Network, United
States
NCT01098292
National Institute of
Diabetes and
Digestive and Kidney … Diseases
Includes health controls and positive
controls. … Diseases
NR NR September 2009--
July 2012
Multi-Disciplinary
Approach to the
Study of Chronic … Pain (MAPP),
United States
5U01DK082344-04
National Institute of
Diabetes and
Digestive and Kidney … Diseases
NR NR September
2008—June 2013
Psychosocial
Treatment for
Gynecology Patients
with
-
effectivehealthcare.ahrq.gov/health-topics/interstitial-cystitis
-
effectivehealthcare.ahrq.gov/health-topics/colonic-polyps
-
effectivehealthcare.ahrq.gov/health-topics/appendicitis
-
effectivehealthcare.ahrq.gov/health-topics/hemorrhoids
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - conditions:
• End-stage liver disease or cirrhosis
• End-stage renal disease (i.e., stage 5 chronic kidney … disease or
dialysis)
• Cancer
• New onset diabetes after an organ transplant
• Cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy
Evidence-based Practice Center Systematic Review Protocol
Project Title: Postpartum Care for Women Up to One Year After Pregnancy
Initial Publication Date: February 24, 2022
Amendment Date: April 25, 2022
(Amendments Details-see Section VI…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
August 01, 2015 - CGMS and insulin pump
Estimated enrollment: 40
National Institute of Diabetes
and Digestive and Kidney … Diseases (NIDDK)
ClinicalTrials.gov
clinicaltrials.gov/ct2/show/NCT01030
341
B-2
http://clinicaltrials.gov … enrollment: 60
In Home Closed Loop Study
Group
National Institute of Diabetes
and Digestive and Kidney … Diseases (NIDDK)
ClinicalTrials.gov
clinicaltrials.gov/ct2/show/NCT01591
681
B-10
http:/
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-learning-objectives-recommendations.pdf
July 01, 2019 - American Journal of Kidney Diseases. 2016 2016;69(2):172-4.
7. Bowater RJ, Escarela G.
-
effectivehealthcare.ahrq.gov/health-topics/gerd
-
effectivehealthcare.ahrq.gov/health-topics/diabetic-diet
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - PULMONARY with "Discussions" in Exec Summary
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 13: Pulmonary Disease, Including Asthma
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Ro…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - been in development to reduce the risk of contrast-induced
nephropathy (CIN) in patients with chronic kidney … disease (CKD) or who have known risk
factors for CIN and who need to undergo imaging that requires